Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Rapid7 (RPD) Beats Q2 Earnings and Revenue Estimates
Rapid7 (RPD) Beats Q2 Earnings and Revenue Estimates

Rapid7 (RPD) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.58 per share a year ago. These figures are

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates

Nektar Therapeutics (NKTR) came out with a quarterly loss of $2.95 per share versus the Zacks Consensus Estimate of a loss of $3.13. This compares to a loss of $3.75 per share a year ago. These

Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to Say
Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Amphastar Pharmaceuticals (AMPH) reported revenue of $174.41 million, down 4.4% over the same period last year. EPS came in at $0.85, compared to $0.94 in the

Akamai Technologies (AKAM) Reports Q2 Earnings: What Key Metrics Have to Say
Akamai Technologies (AKAM) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Akamai Technologies (AKAM) reported revenue of $1.04 billion, up 6.5% over the same period last year. EPS came in at $1.73, compared to $1.58 in the year-ago

Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates
Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates

Gen Digital (GEN) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.53 per share a year ago. These figures

Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates

Doximity (DOCS) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.28 per share a year ago. These figures

AudioEye (AEYE) Q2 Earnings and Revenues Miss Estimates
AudioEye (AEYE) Q2 Earnings and Revenues Miss Estimates

AudioEye (AEYE) came out with quarterly earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.12 per share a year ago. These figures

PTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates
PTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates

PTC Therapeutics (PTCT) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to a loss of $1.16 per share a year ago. These figures

Nerdy Inc. (NRDY) Reports Q2 Loss, Lags Revenue Estimates
Nerdy Inc. (NRDY) Reports Q2 Loss, Lags Revenue Estimates

Nerdy Inc. (NRDY) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.08 per share a year ago. These figures are

Monster Beverage (MNST) Tops Q2 Earnings and Revenue Estimates
Monster Beverage (MNST) Tops Q2 Earnings and Revenue Estimates

Monster Beverage (MNST) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.41 per share a year ago. These

Turtle Beach (TBCH) Reports Q2 Loss, Misses Revenue Estimates
Turtle Beach (TBCH) Reports Q2 Loss, Misses Revenue Estimates

Turtle Beach (TBCH) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.3 per share a year ago. These figures are

Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates
Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates

Solventum (SOLV) came out with quarterly earnings of $1.69 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.56 per share a year ago. These figures

Consensus Cloud Solutions, Inc. (CCSI) Q2 Earnings and Revenues Top Estimates
Consensus Cloud Solutions, Inc. (CCSI) Q2 Earnings and Revenues Top Estimates

Consensus Cloud Solutions, Inc. (CCSI) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.45 per share a

CytomX Therapeutics (CTMX) Reports Break-Even Earnings for Q2
CytomX Therapeutics (CTMX) Reports Break-Even Earnings for Q2

CytomX Therapeutics (CTMX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.08 per share a year ago. These

EOG Resources (EOG) Surpasses Q2 Earnings and Revenue Estimates
EOG Resources (EOG) Surpasses Q2 Earnings and Revenue Estimates

EOG Resources (EOG) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $3.16 per share a year ago. These

HireQuest, Inc. (HQI) Q2 Earnings and Revenues Top Estimates
HireQuest, Inc. (HQI) Q2 Earnings and Revenues Top Estimates

HireQuest, Inc. (HQI) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.15 per share a year ago. These

Maplebear (CART) Q2 Earnings and Revenues Beat Estimates
Maplebear (CART) Q2 Earnings and Revenues Beat Estimates

Maplebear (CART) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.2 per share a year ago. These figures

Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $0.51 per share a year ago

GoDaddy (GDDY) Q2 Earnings and Revenues Top Estimates
GoDaddy (GDDY) Q2 Earnings and Revenues Top Estimates

GoDaddy (GDDY) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.1 per share a year ago. These figures are

GigaCloud Technology Inc. (GCT) Q2 Earnings and Revenues Surpass Estimates
GigaCloud Technology Inc. (GCT) Q2 Earnings and Revenues Surpass Estimates

GigaCloud Technology Inc. (GCT) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.65 per share a year ago

Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.08 per share a year ago. These figures

BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2

BioLife Solutions, Inc. (BLFS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.06 per share a year ago. These

Akamai Technologies (AKAM) Surpasses Q2 Earnings and Revenue Estimates
Akamai Technologies (AKAM) Surpasses Q2 Earnings and Revenue Estimates

Akamai Technologies (AKAM) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.58 per share a year ago

Clipper Realty Inc. (CLPR) Beats Q2 FFO Estimates
Clipper Realty Inc. (CLPR) Beats Q2 FFO Estimates

Clipper Realty Inc. (CLPR) came out with quarterly funds from operations (FFO) of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to FFO of $0.17 per share a

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates

Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.94 per share a year